Identification and characterization of the cellular regulators of Respiratory Syncytial virus infection
Description of the granted funding
Respiratory syncytial virus (RSV) is the leading cause of viral infant death in the world. Every year, RSV is responsible for more than 30 million infections in children younger than 5 years of age, of which up to 200.000 die of the disease. In Finland, RSV has a similar incidence. No licenced vaccines are available for RSV. Most antiviral compounds usually target viral components. An alternative strategy is to target the host cell rather than the pathogen. The identification of key cellular regulators of RSV is one of the main goals of current research aimed at developing novel anti-RSV therapies. Using a combination of genetic screening approaches (siRNA and CRISPRs) and a variety of state-of-the-art super-resolution imaging techniques the research presented in this proposal aims at revealing novel cellular regulators of RSV infection and new methods to inhibit it.
Show moreStarting year
2018
End year
2023
Granted funding
Related funding decisions
345506
Research costs of Academy Research Fellows(2021)
139 999 €
319954
Research costs of Academy Research Fellows(2018)
250 000 €
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Other information
Funding decision number
318434
Fields of science
Plant biology, microbiology, virology
Research fields
Mikrobiologia
Identified topics
covid, pandemic, vaccines